(IN BRIEF) AstraZeneca will present significant cancer research at the 2024 World Conference on Lung Cancer (WCLC) and the European…
(IN BRIEF) Sanofi's phase 3 study for its drug tolebrutinib has shown promising results in treating non-relapsing secondary progressive multiple…
(IN BRIEF) Roche has received approval from the European Commission for PiaSky® (crovalimab), a novel treatment for paroxysmal nocturnal haemoglobinuria…
(IN BRIEF) Brenntag has expanded its presence in Brazil’s Life Science market with the acquisition of specialty chemicals distributors PIC…
(IN BRIEF) SISTO Armaturen S.A., part of the KSB Group, has developed the SISTO-CM1300, an automated multi-port valve designed to…
(IN BRIEF) Eckert & Ziegler has signed a multi-year agreement with Telix Pharmaceuticals to serve as the European contract manufacturing…
(IN BRIEF) Evotec SE has made significant progress in its strategic partnership with Bristol Myers Squibb, focused on developing a…
(IN BRIEF) AstraZeneca and Daiichi Sankyo's Enhertu has received conditional approval in China for treating locally advanced or metastatic HER2-positive…
(IN BRIEF) Professor Remco Tuinier and his team at Eindhoven University of Technology have developed a new method to slow…
(IN BRIEF) Tubulis has been named one of 2024’s “Fierce 15” biotechnology companies by Fierce Biotech. This recognition celebrates Tubulis’…